Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1980 3
1981 4
1982 5
1983 1
1984 1
1985 4
1986 2
1987 5
1988 9
1989 10
1990 7
1991 6
1992 5
1993 9
1994 8
1995 3
1996 6
1997 5
1998 10
1999 4
2000 6
2001 7
2002 12
2003 6
2004 11
2005 4
2006 9
2007 7
2008 13
2009 7
2010 13
2011 13
2012 10
2013 10
2014 16
2015 20
2016 10
2017 12
2018 22
2019 18
2020 19
2021 14
2022 11
2023 10
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

367 results

Results by year

Filters applied: . Clear all
Page 1
Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741.
Citron ML, Berry DA, Cirrincione C, Hudis C, Winer EP, Gradishar WJ, Davidson NE, Martino S, Livingston R, Ingle JN, Perez EA, Carpenter J, Hurd D, Holland JF, Smith BL, Sartor CI, Leung EH, Abrams J, Schilsky RL, Muss HB, Norton L. Citron ML, et al. Among authors: schilsky rl. J Clin Oncol. 2003 Apr 15;21(8):1431-9. doi: 10.1200/JCO.2003.09.081. Epub 2003 Feb 13. J Clin Oncol. 2003. PMID: 12668651 Clinical Trial.
Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial.
Venook AP, Niedzwiecki D, Lenz HJ, Innocenti F, Fruth B, Meyerhardt JA, Schrag D, Greene C, O'Neil BH, Atkins JN, Berry S, Polite BN, O'Reilly EM, Goldberg RM, Hochster HS, Schilsky RL, Bertagnolli MM, El-Khoueiry AB, Watson P, Benson AB 3rd, Mulkerin DL, Mayer RJ, Blanke C. Venook AP, et al. Among authors: schilsky rl. JAMA. 2017 Jun 20;317(23):2392-2401. doi: 10.1001/jama.2017.7105. JAMA. 2017. PMID: 28632865 Free PMC article. Clinical Trial.
Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review.
Merker JD, Oxnard GR, Compton C, Diehn M, Hurley P, Lazar AJ, Lindeman N, Lockwood CM, Rai AJ, Schilsky RL, Tsimberidou AM, Vasalos P, Billman BL, Oliver TK, Bruinooge SS, Hayes DF, Turner NC. Merker JD, et al. Among authors: schilsky rl. J Clin Oncol. 2018 Jun 1;36(16):1631-1641. doi: 10.1200/JCO.2017.76.8671. Epub 2018 Mar 5. J Clin Oncol. 2018. PMID: 29504847 Review.
Response.
Jardim DL, Schwaederle M, Lee JJ, Wei C, Mendelsohn J, Schilsky RL, Kurzrock R. Jardim DL, et al. Among authors: schilsky rl. J Natl Cancer Inst. 2016 Feb 24;108(3):djw001. doi: 10.1093/jnci/djw001. Print 2016 Mar. J Natl Cancer Inst. 2016. PMID: 26912651 No abstract available.
Use of Biosimilar Medications in Oncology.
Nahleh Z, Lyman GH, Schilsky RL, Peterson DE, Tagawa ST, Chavez-MacGregor M, Rumble RB, Gupta S. Nahleh Z, et al. Among authors: schilsky rl. JCO Oncol Pract. 2022 Mar;18(3):177-186. doi: 10.1200/OP.21.00771. Epub 2022 Jan 18. JCO Oncol Pract. 2022. PMID: 35041524 Review.
Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups.
Strauss GM, Herndon JE 2nd, Maddaus MA, Johnstone DW, Johnson EA, Harpole DH, Gillenwater HH, Watson DM, Sugarbaker DJ, Schilsky RL, Vokes EE, Green MR. Strauss GM, et al. Among authors: schilsky rl. J Clin Oncol. 2008 Nov 1;26(31):5043-51. doi: 10.1200/JCO.2008.16.4855. Epub 2008 Sep 22. J Clin Oncol. 2008. PMID: 18809614 Free PMC article. Clinical Trial.
Implementing personalized cancer care.
Schilsky RL. Schilsky RL. Nat Rev Clin Oncol. 2014 Jul;11(7):432-8. doi: 10.1038/nrclinonc.2014.54. Epub 2014 Apr 1. Nat Rev Clin Oncol. 2014. PMID: 24687035 Review.
Talking the Talk About Tumor Genomic Testing.
Schilsky RL. Schilsky RL. J Natl Cancer Inst. 2020 May 1;112(5):436-437. doi: 10.1093/jnci/djz175. J Natl Cancer Inst. 2020. PMID: 31675090 Free PMC article. No abstract available.
Converging on the Value of Value Frameworks.
Schnipper LE, Schilsky RL. Schnipper LE, et al. Among authors: schilsky rl. J Clin Oncol. 2017 Aug 20;35(24):2732-2734. doi: 10.1200/JCO.2017.73.5704. Epub 2017 Jun 6. J Clin Oncol. 2017. PMID: 28586244 No abstract available.
Optimizing dosing of oncology drugs.
Minasian L, Rosen O, Auclair D, Rahman A, Pazdur R, Schilsky RL. Minasian L, et al. Among authors: schilsky rl. Clin Pharmacol Ther. 2014 Nov;96(5):572-9. doi: 10.1038/clpt.2014.153. Epub 2014 Aug 8. Clin Pharmacol Ther. 2014. PMID: 25105705 Review.
367 results